Foresite Capital Management III as of June 30, 2020
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 8 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Myokardia | 34.3 | $39M | 399k | 96.62 | |
| Blueprint Medicines (BPMC) | 17.3 | $20M | 250k | 78.00 | |
| Oric Pharmaceuticals (ORIC) | 14.9 | $17M | 497k | 33.73 | |
| Epizyme | 14.3 | $16M | 998k | 16.06 | |
| Natera (NTRA) | 9.3 | $10M | 209k | 49.86 | |
| Cymabay Therapeutics | 5.0 | $5.6M | 1.6M | 3.49 | |
| Acceleron Pharma | 3.6 | $4.0M | 42k | 95.27 | |
| Fibrogen (FGEN) | 1.4 | $1.6M | 40k | 40.52 |
